Does Therapeutic Dose of Sildenafil Citrate Treatment Lead to Central Serous Chorioretinopathy in Patients With Erectile Dysfunction?
The possible effects of sildenafil citrate administration at therapeutic dosage on visual acuity, color vision, intraocular pressure, macular thickness, macular volume, and central serous chorioretinopathy in patients with erectile dysfunction were evaluated. The study consisted of 43 male patients...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2013-09-01
|
| Series: | American Journal of Men's Health |
| Online Access: | https://doi.org/10.1177/1557988313480808 |
| _version_ | 1819169995374985216 |
|---|---|
| author | Elif Damar MD Yasin Toklu MD Altug Tuncel MD Melih Balci MD Yilmaz Aslan MD Saban Simsek MD Ali Atan MD |
| author_facet | Elif Damar MD Yasin Toklu MD Altug Tuncel MD Melih Balci MD Yilmaz Aslan MD Saban Simsek MD Ali Atan MD |
| author_sort | Elif Damar MD |
| collection | DOAJ |
| description | The possible effects of sildenafil citrate administration at therapeutic dosage on visual acuity, color vision, intraocular pressure, macular thickness, macular volume, and central serous chorioretinopathy in patients with erectile dysfunction were evaluated. The study consisted of 43 male patients diagnosed as having erectile dysfunction according to the first five question version of International Index of Erectile Function (IIEF-5). All patients were given sildenafil citrate 50 mg po 2 to 3 times/week for a month. The patients were evaluated at the first week and at the end of the treatment. The macular thickness and volume assessments with optic coherence tomography did not differ significantly in foveal, parafoveal areas, parafoveal superior hemisphere, parafoveal inferior hemisphere, parafoveal temporal, superior, nasal, and inferior quadrants. Central serous chorioretinopathy was not found in any of the patients. |
| first_indexed | 2024-12-22T19:28:21Z |
| format | Article |
| id | doaj.art-b2a8d4f4cd304dc19585f546f40a88b9 |
| institution | Directory Open Access Journal |
| issn | 1557-9883 1557-9891 |
| language | English |
| last_indexed | 2024-12-22T19:28:21Z |
| publishDate | 2013-09-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | American Journal of Men's Health |
| spelling | doaj.art-b2a8d4f4cd304dc19585f546f40a88b92022-12-21T18:15:10ZengSAGE PublishingAmerican Journal of Men's Health1557-98831557-98912013-09-01710.1177/1557988313480808Does Therapeutic Dose of Sildenafil Citrate Treatment Lead to Central Serous Chorioretinopathy in Patients With Erectile Dysfunction?Elif Damar MD0Yasin Toklu MD1Altug Tuncel MD2Melih Balci MD3Yilmaz Aslan MD4Saban Simsek MD5Ali Atan MD6 Ministry of Health, Ankara Ataturk Research and Training Hospital, Department of Ophthalmology, Ankara, Turkey Ministry of Health, Ankara Ataturk Research and Training Hospital, Department of Ophthalmology, Ankara, Turkey Ministry of Health, Ankara Numune Research and Training Hospital, Third Department of Urology, Ankara, Turkey Ministry of Health, Ankara Numune Research and Training Hospital, Third Department of Urology, Ankara, Turkey Ministry of Health, Ankara Numune Research and Training Hospital, Third Department of Urology, Ankara, Turkey Ministry of Health, Ankara Ataturk Research and Training Hospital, Department of Ophthalmology, Ankara, Turkey Ministry of Health, Ankara Numune Research and Training Hospital, Third Department of Urology, Ankara, TurkeyThe possible effects of sildenafil citrate administration at therapeutic dosage on visual acuity, color vision, intraocular pressure, macular thickness, macular volume, and central serous chorioretinopathy in patients with erectile dysfunction were evaluated. The study consisted of 43 male patients diagnosed as having erectile dysfunction according to the first five question version of International Index of Erectile Function (IIEF-5). All patients were given sildenafil citrate 50 mg po 2 to 3 times/week for a month. The patients were evaluated at the first week and at the end of the treatment. The macular thickness and volume assessments with optic coherence tomography did not differ significantly in foveal, parafoveal areas, parafoveal superior hemisphere, parafoveal inferior hemisphere, parafoveal temporal, superior, nasal, and inferior quadrants. Central serous chorioretinopathy was not found in any of the patients.https://doi.org/10.1177/1557988313480808 |
| spellingShingle | Elif Damar MD Yasin Toklu MD Altug Tuncel MD Melih Balci MD Yilmaz Aslan MD Saban Simsek MD Ali Atan MD Does Therapeutic Dose of Sildenafil Citrate Treatment Lead to Central Serous Chorioretinopathy in Patients With Erectile Dysfunction? American Journal of Men's Health |
| title | Does Therapeutic Dose of Sildenafil Citrate Treatment Lead to Central Serous Chorioretinopathy in Patients With Erectile Dysfunction? |
| title_full | Does Therapeutic Dose of Sildenafil Citrate Treatment Lead to Central Serous Chorioretinopathy in Patients With Erectile Dysfunction? |
| title_fullStr | Does Therapeutic Dose of Sildenafil Citrate Treatment Lead to Central Serous Chorioretinopathy in Patients With Erectile Dysfunction? |
| title_full_unstemmed | Does Therapeutic Dose of Sildenafil Citrate Treatment Lead to Central Serous Chorioretinopathy in Patients With Erectile Dysfunction? |
| title_short | Does Therapeutic Dose of Sildenafil Citrate Treatment Lead to Central Serous Chorioretinopathy in Patients With Erectile Dysfunction? |
| title_sort | does therapeutic dose of sildenafil citrate treatment lead to central serous chorioretinopathy in patients with erectile dysfunction |
| url | https://doi.org/10.1177/1557988313480808 |
| work_keys_str_mv | AT elifdamarmd doestherapeuticdoseofsildenafilcitratetreatmentleadtocentralserouschorioretinopathyinpatientswitherectiledysfunction AT yasintoklumd doestherapeuticdoseofsildenafilcitratetreatmentleadtocentralserouschorioretinopathyinpatientswitherectiledysfunction AT altugtuncelmd doestherapeuticdoseofsildenafilcitratetreatmentleadtocentralserouschorioretinopathyinpatientswitherectiledysfunction AT melihbalcimd doestherapeuticdoseofsildenafilcitratetreatmentleadtocentralserouschorioretinopathyinpatientswitherectiledysfunction AT yilmazaslanmd doestherapeuticdoseofsildenafilcitratetreatmentleadtocentralserouschorioretinopathyinpatientswitherectiledysfunction AT sabansimsekmd doestherapeuticdoseofsildenafilcitratetreatmentleadtocentralserouschorioretinopathyinpatientswitherectiledysfunction AT aliatanmd doestherapeuticdoseofsildenafilcitratetreatmentleadtocentralserouschorioretinopathyinpatientswitherectiledysfunction |